Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaye
H Obstfeld

Showing results (411-420 of 430) with videos related to

Pageof 43
Sort By:
Rheumatology and Therapy|July 31, 2021
Novel Interventional Techniques for Chronic Pain with Minimally Invasive Arthrodesis of the Sacroiliac Joint: (INSITE, iFuse, Tricor, Rialto, and others)Alan D Kaye, Amber N Edinoff, Logan Scoon, et al.
The Journal of Clinical Investigation|April 30, 2019
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survivalPatrick Kellish, Daniil Shabashvili, Masmudur M Rahman, et al.
Best Practice & Research. Clinical Anaesthesiology|December 4, 2019
Newer nerve blocks in pediatric surgeryAlan D Kaye, Jeremy B Green, Kelly S Davidson, et al.
The Journal of Clinical Investigation|May 4, 2016
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growthZirong Chen, Jian-Liang Li, Shuibin Lin, et al.
Orphanet Journal of Rare Diseases|November 10, 2016
The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseasesM K Javaid, L Forestier-Zhang, L Watts, et al.
Anesthesiology and Pain Medicine|September 20, 2021
Adjuvant Drugs for Peripheral Nerve Blocks: The Role of NMDA Antagonists, Neostigmine, Epinephrine, and Sodium BicarbonateAmber N Edinoff, Joseph S Fitz-Gerald, Krisha Andrea A Holland, et al.
Cell Death Discovery|January 1, 2023
Co-targeting BCL-X<sub>L</sub> and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in miceSajid Khan, Patrick Kellish, Nick Connis, et al.
Internal Medicine Journal|November 6, 2014
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in AustraliaS Xu, K Alexander, W Bryant, et al.
Science (New York, N.Y.)|May 1, 2004
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyJ Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Pageof 43

Showing results (411-420 of 430) with videos related to

Sort By:
Pageof 43
Rheumatology and Therapy|July 31, 2021
Novel Interventional Techniques for Chronic Pain with Minimally Invasive Arthrodesis of the Sacroiliac Joint: (INSITE, iFuse, Tricor, Rialto, and others)Alan D Kaye, Amber N Edinoff, Logan Scoon, et al.
The Journal of Clinical Investigation|April 30, 2019
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survivalPatrick Kellish, Daniil Shabashvili, Masmudur M Rahman, et al.
Best Practice & Research. Clinical Anaesthesiology|December 4, 2019
Newer nerve blocks in pediatric surgeryAlan D Kaye, Jeremy B Green, Kelly S Davidson, et al.
The Journal of Clinical Investigation|May 4, 2016
cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growthZirong Chen, Jian-Liang Li, Shuibin Lin, et al.
Orphanet Journal of Rare Diseases|November 10, 2016
The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseasesM K Javaid, L Forestier-Zhang, L Watts, et al.
Anesthesiology and Pain Medicine|September 20, 2021
Adjuvant Drugs for Peripheral Nerve Blocks: The Role of NMDA Antagonists, Neostigmine, Epinephrine, and Sodium BicarbonateAmber N Edinoff, Joseph S Fitz-Gerald, Krisha Andrea A Holland, et al.
Cell Death Discovery|January 1, 2023
Co-targeting BCL-X<sub>L</sub> and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in miceSajid Khan, Patrick Kellish, Nick Connis, et al.
Internal Medicine Journal|November 6, 2014
Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in AustraliaS Xu, K Alexander, W Bryant, et al.
Science (New York, N.Y.)|May 1, 2004
EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapyJ Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Pageof 43